Skip to main content

  • Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials

    • Posted: 03/22/2019
    • Author:

      Poonam Velagapudi, Mohit Turagam, Dhaval Kolte, Sahil Khera, Omar Hyder, Paul Gordon, Herbert D. Aronow, Jane Leopold and J. Dawn Abbott

    • 2019CRM

    Abstract

    Background

    Previous studies have demonstrated that intramyocardial human CD34+ cells may relieve symptoms and improve clinical outcomes in chronic refractory angina unresponsive to optimal medical therapy or not amenable to revascularization.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details